Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.

Mozzillo N, Pasquali S, Santinami M, Testori A, Di Marzo M, Crispo A, Patuzzo R, Verrecchia F, Botti G, Montella M, Rossi CR, Caracò C.

Eur J Surg Oncol. 2015 Mar 11. pii: S0748-7983(15)00078-5. doi: 10.1016/j.ejso.2015.02.005. [Epub ahead of print]

PMID:
25800935
2.

AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment.

Caputo E, Miceli R, Motti ML, Taté R, Fratangelo F, Botti G, Mozzillo N, Carriero MV, Cavalcanti E, Palmieri G, Ciliberto G, Pirozzi G, Ascierto PA.

J Transl Med. 2015;13:2069. doi: 10.1186/1479-5876-13-S1-P1. No abstract available.

3.

Surgery in the combination therapies era.

Mozzillo N.

J Transl Med. 2015;13:2049. doi: 10.1186/1479-5876-13-S1-K11. No abstract available.

4.

Report from the second MIB (Melanoma Independent Board) Conference, 27-28 October 2014.

Testori A, Rossi CR, Ascierto P, de Lorenzo F, Mozzillo N.

Ecancermedicalscience. 2015 Feb 19;9:511. doi: 10.3332/ecancer.2015.511. eCollection 2015.

5.

Vemurafenib beyond progression in a patient with metastatic melanoma: a case report.

Grimaldi AM, Simeone E, Palla M, Festino L, Caracò C, Mozzillo N, Petrillo A, Muto P, Ascierto PA.

Anticancer Drugs. 2015 Apr;26(4):464-8. doi: 10.1097/CAD.0000000000000206.

PMID:
25622086
6.

Ran signaling in melanoma: implications for the development of alternative therapeutic strategies.

Caputo E, Wang E, Valentino A, Crispi S, De Giorgi V, Fico A, Ficili B, Capone M, Anniciello A, Cavalcanti E, Botti G, Mozzillo N, Ascierto PA, Marincola FM, Travali S.

Cancer Lett. 2015 Feb 1;357(1):286-96. doi: 10.1016/j.canlet.2014.11.033. Epub 2014 Nov 20.

PMID:
25444926
7.

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

Ascierto PA, Grimaldi AM, Anderson AC, Bifulco C, Cochran A, Garbe C, Eggermont AM, Faries M, Ferrone S, Gershenwald JE, Gajewski TF, Halaban R, Hodi FS, Kefford R, Kirkwood JM, Larkin J, Leachman S, Maio M, Marais R, Masucci G, Melero I, Palmieri G, Puzanov I, Ribas A, Saenger Y, Schilling B, Seliger B, Stroncek D, Sullivan R, Testori A, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M.

J Transl Med. 2014 Oct 28;12:277. doi: 10.1186/s12967-014-0277-z.

8.

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.

Grimaldi AM, Simeone E, Giannarelli D, Muto P, Falivene S, Borzillo V, Giugliano FM, Sandomenico F, Petrillo A, Curvietto M, Esposito A, Paone M, Palla M, Palmieri G, Caracò C, Ciliberto G, Mozzillo N, Ascierto PA.

Oncoimmunology. 2014 May 14;3:e28780. eCollection 2014.

9.

AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment.

Caputo E, Miceli R, Motti ML, Taté R, Fratangelo F, Botti G, Mozzillo N, Carriero MV, Cavalcanti E, Palmieri G, Ciliberto G, Pirozzi G, Ascierto PA.

J Transl Med. 2014 Jul 31;12:216. doi: 10.1186/s12967-014-0216-z.

10.

Melanoma: the role of surgery in the era of new therapies.

Mozzillo N, Ascierto PA.

J Transl Med. 2014 Jul 11;12:195. doi: 10.1186/1479-5876-12-195. No abstract available.

11.

Serious haematological toxicity during and after ipilimumab treatment: a case series.

Simeone E, Grimaldi AM, Esposito A, Curvietto M, Palla M, Paone M, Mozzillo N, Ascierto PA.

J Med Case Rep. 2014 Jul 1;8:240. doi: 10.1186/1752-1947-8-240.

12.

Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma.

Rossi CR, Mozzillo N, Maurichi A, Pasquali S, Macripò G, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Mocellin S, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M.

JAMA Surg. 2014 Jul;149(7):700-6. doi: 10.1001/jamasurg.2013.5676.

PMID:
24804856
13.

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.

Simeone E, Gentilcore G, Giannarelli D, Grimaldi AM, Caracò C, Curvietto M, Esposito A, Paone M, Palla M, Cavalcanti E, Sandomenico F, Petrillo A, Botti G, Fulciniti F, Palmieri G, Queirolo P, Marchetti P, Ferraresi V, Rinaldi G, Pistillo MP, Ciliberto G, Mozzillo N, Ascierto PA.

Cancer Immunol Immunother. 2014 Jul;63(7):675-83. doi: 10.1007/s00262-014-1545-8. Epub 2014 Apr 3. Erratum in: Cancer Immunol Immunother. 2014 Nov;63(11):1233.

PMID:
24695951
14.

Treatment of metastatic melanoma with electrochemotherapy.

Campana LG, Testori A, Mozzillo N, Rossi CR.

J Surg Oncol. 2014 Mar;109(4):301-7. Review.

PMID:
24678530
15.

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang HJ, Elashoff R, Faries MB; MSLT Group.

N Engl J Med. 2014 Feb 13;370(7):599-609. doi: 10.1056/NEJMoa1310460.

16.

Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.

Pasquali S, Mocellin S, Mozzillo N, Maurichi A, Quaglino P, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M, Rossi CR.

J Clin Oncol. 2014 Mar 20;32(9):935-41. doi: 10.1200/JCO.2013.50.7681. Epub 2014 Feb 10.

17.

The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis.

Rossi CR, Mozzillo N, Maurichi A, Pasquali S, Quaglino P, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Mocellin S, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M.

Ann Oncol. 2014 Jan;25(1):240-6. doi: 10.1093/annonc/mdt510.

18.

Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis.

Caracò C, Mozzillo N, Marone U, Simeone E, Benedetto L, Di Monta G, Di Cecilia ML, Botti G, Ascierto PA.

BMC Cancer. 2013 Dec 1;13:564. doi: 10.1186/1471-2407-13-564.

19.

Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.

Han D, Zager JS, Shyr Y, Chen H, Berry LD, Iyengar S, Djulbegovic M, Weber JL, Marzban SS, Sondak VK, Messina JL, Vetto JT, White RL, Pockaj B, Mozzillo N, Charney KJ, Avisar E, Krouse R, Kashani-Sabet M, Leong SP.

J Clin Oncol. 2013 Dec 10;31(35):4387-93. doi: 10.1200/JCO.2013.50.1114. Epub 2013 Nov 4.

20.

Surgical management of sentinel lymph node biopsy outside major nodal basin in patients with cutaneous melanoma.

Caracò C, Marone U, Di Monta G, Aloj L, Caracò C, Anniciello A, Lastoria S, Botti G, Mozzillo N.

Ann Surg Oncol. 2014 Jan;21(1):300-5. doi: 10.1245/s10434-013-3285-y. Epub 2013 Oct 1.

PMID:
24081802
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk